HF
RCKT icon

HRT Financial’s Rocket Pharmaceuticals RCKT Stock Holding History

HRT Financial’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-109,797
Closed -$385K – 4566
2025
Q4 		$385K Buy
+109,797
New +$376K ﹤0.01% 2245
2024
Q4 		– Sell
-26,149
Closed -$482K – 3077
2024
Q3 		$482K Buy
+26,149
New +$536K ﹤0.01% 1600
2023
Q4 		– Sell
-65,176
Closed -$1.33M – 2939
2023
Q3 		$1.33M Buy
65,176
+32,162
+97% +$585K 0.01% 824
2023
Q2 		$655K Buy
+33,014
New +$667K 0.01% 1211
2022
Q1 		– Sell
-36,251
Closed -$791K – 3724
2021
Q4 		$791K Buy
+36,251
New +$989K ﹤0.01% 1323
2021
Q1 		– Sell
-18,470
Closed -$1.01M – 3070
2020
Q4 		$1.01M Buy
+18,470
New +$673K 0.02% 660
2019
Q1 		– Sell
-12,704
Closed -$188K – 738
2018
Q4 		$188K Buy
+12,704
New +$211K 0.03% 490

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

HRT Financial's RCKT Position: Q1 2026 in Review

HRT Financial sold out of Rocket Pharmaceuticals (RCKT) in Q1 2026, closing a stake of 109,797 shares — an estimated $385K sold.

HRT Financial first reported a position in RCKT in Q4 2018 and held it in 7 quarters. The position peaked at $1.33M in Q3 2023. 199 funds tracked by Wall St. Rank hold RCKT as of Q1 2026.

  • HRT Financial reported no remaining Rocket Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 109,797 Rocket Pharmaceuticals shares in Q1 2026, an estimated $385K.
  • HRT Financial first reported a position in Rocket Pharmaceuticals in Q4 2018 and held it in 7 quarters.
  • HRT Financial's Rocket Pharmaceuticals position peaked at $1.33M in Q3 2023.
  • 199 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.